Xenon Pharmaceuticals Inc. (XENE) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 7.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 132K | 536K | 8.77M | 3.74M | 8.12M | 2.22M |
| Revenue Growth % | -100% | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -98.38% | -75.83% | 101.15% | -27.44% | 23.95% | -83.43% |
| Cost of Goods Sold | 0 | 611K | 77.05M | 632K | 0 | 0 | 0 | 0 | 599K | 0 | 0 | 0 | 0 | 0 | 29.43M | 22.15M | 19.36M | 21.89M | 18.89M | 18.38M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22296.21% | 4131.72% | 220.85% | 585.68% | 232.53% | 828.54% |
| Gross Profit | 0 | -611K | -77.05M | -632K | 7.5M | 0 | 0 | 0 | -599K | 0 | 0 | 0 | 0 | 0 | -29.3M | -21.61M | -10.59M | -18.15M | -10.77M | -16.16M |
| Gross Margin % | - | - | - | - | 100% | - | - | - | - | - | - | - | - | - | -22196.21% | -4031.72% | -120.85% | -485.68% | -132.53% | -728.54% |
| Gross Profit Growth % | -100% | - | - | - | 1352.09% | - | - | - | - | - | 100% | 100% | 100% | 100% | -172.12% | -33.73% | 11.35% | -84.88% | -264.28% | -220.73% |
| Operating Expenses | 112.33M | 109.16M | 19.28M | 93.6M | 80.24M | 77.48M | 73.68M | 69.1M | 58.44M | 53.7M | 55.68M | 55.62M | 49.05M | 43.33M | 8.83M | 8.71M | 6.78M | 6.69M | 4.83M | 6.34M |
| OpEx % of Revenue | - | - | - | - | 1069.84% | - | - | - | - | - | - | - | - | - | 6688.64% | 1624.07% | 77.29% | 178.97% | 59.47% | 285.8% |
| Selling, General & Admin | 23.82M | 22.07M | 19.28M | 19.24M | 19.04M | 18M | 16.71M | 19.4M | 14.19M | 12.62M | 12.8M | 11.58M | 9.54M | 8.5M | 8.83M | 8.71M | 6.78M | 6.69M | 4.83M | 6.34M |
| SG&A % of Revenue | - | - | - | - | 253.84% | - | - | - | - | - | - | - | - | - | 6688.64% | 1624.07% | 77.29% | 178.97% | 59.47% | 285.8% |
| Research & Development | 88.51M | 87.7M | 77.05M | 74.98M | 61.2M | 59.47M | 56.97M | 49.7M | 44.25M | 41.08M | 42.88M | 44.04M | 39.52M | 34.83M | 29.43M | 22.15M | 19.36M | 21.89M | 18.89M | 18.38M |
| R&D % of Revenue | - | - | - | - | 816% | - | - | - | - | - | - | - | - | - | 22296.21% | 4131.72% | 220.85% | 585.68% | 232.53% | 828.54% |
| Other Operating Expenses | 0 | -611K | -1000K | -632K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -112.33M | -109.77M | -96.34M | -94.23M | -72.74M | -77.48M | -73.68M | -69.1M | -59.04M | -53.7M | -55.68M | -55.62M | -49.05M | -43.33M | -38.13M | -30.32M | -17.37M | -24.84M | -15.6M | -22.5M |
| Operating Margin % | - | - | - | - | -969.84% | - | - | - | - | - | - | - | - | - | -28884.85% | -5655.78% | -198.14% | -664.65% | -192% | -1014.34% |
| Operating Income Growth % | -54.43% | -41.68% | -30.76% | -36.36% | -23.2% | -44.29% | -32.31% | -24.23% | -20.37% | -23.92% | -46.04% | -83.49% | -182.41% | -74.45% | -144.44% | -34.75% | -8.16% | -92.2% | -60.82% | -3382.66% |
| EBITDA | -111.74M | -109.16M | -95.69M | -93.6M | -72.08M | -76.84M | -72.98M | -68.46M | -58.44M | -52.84M | -53.95M | -55.02M | -48.7M | -42.82M | -37.77M | -29.94M | -16.99M | -24.57M | -15.39M | -22.27M |
| EBITDA Margin % | - | - | - | - | -961.05% | - | - | - | - | - | - | - | - | - | -28613.64% | -5585.82% | -193.85% | -657.43% | -189.43% | -1003.92% |
| EBITDA Growth % | -55.03% | -42.05% | -31.13% | -36.71% | -23.33% | -45.42% | -35.27% | -24.43% | -20.01% | -23.42% | -42.84% | -83.77% | -186.57% | -74.28% | -145.44% | -34.46% | -7.12% | -93.13% | -61.51% | -4548.64% |
| D&A (Non-Cash Add-back) | 587K | 611K | 641K | 632K | 659K | 633K | 700K | 641K | 599K | 851K | 1.73M | 602K | 354K | 515K | 358K | 375K | 376K | 270K | 209K | 231K |
| EBIT | -112.33M | -104.72M | -90.22M | -94.23M | -72.74M | -77.48M | -73.68M | -69.1M | -59.04M | -53.7M | -55.68M | -55.62M | -49.05M | -39.44M | -38.13M | -30.32M | -17.37M | -24.84M | -15.6M | -22.5M |
| Net Interest Income | 6.91M | 6.21M | 6.21M | 7.2M | 8.08M | 9.42M | 10.33M | 10.84M | 11.36M | 8.69M | 6.98M | 6.52M | 5.42M | 4.46M | 3.07M | 816K | 368K | 263K | 57K | 72K |
| Interest Income | 6.91M | 6.21M | 6.21M | 7.2M | 8.08M | 9.42M | 10.33M | 10.84M | 11.36M | 8.69M | 6.98M | 6.52M | 5.42M | 4.46M | 3.07M | 816K | 368K | 263K | 76K | 72K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19K | 0 |
| Other Income/Expense | 7.46M | 5.04M | 6.12M | 8.9M | 8.12M | 7.94M | 10.57M | 10.85M | 11.52M | 8.75M | 7.07M | 7.94M | 7.61M | 7.08M | 391K | -883K | -2.69M | -242K | -52K | 172K |
| Pretax Income | -104.87M | -104.72M | -90.22M | -85.33M | -64.62M | -69.53M | -63.11M | -58.26M | -47.52M | -44.95M | -48.62M | -47.68M | -41.44M | -36.26M | -37.74M | 31.2M | -20.06M | -25.08M | -15.65M | -22.33M |
| Pretax Margin % | - | - | - | - | -861.6% | - | - | - | - | - | - | - | - | - | -28588.64% | 5820.52% | -228.88% | -671.13% | -192.64% | -1006.58% |
| Income Tax | -2.57M | 538K | 677K | -626K | 427K | -3.85M | -320K | -333K | 412K | -205K | -157K | -220K | 290K | 1.14M | -587K | 40K | -394K | 484K | -205K | -217K |
| Effective Tax Rate % | 2.45% | -0.51% | -0.75% | 0.73% | -0.66% | 5.53% | 0.51% | 0.57% | -0.87% | 0.46% | 0.32% | 0.46% | -0.7% | -3.14% | 1.56% | 0.13% | 1.96% | -1.93% | 1.31% | 0.97% |
| Net Income | -102.3M | -105.26M | -90.9M | -84.71M | -65.05M | -65.69M | -62.79M | -57.92M | -47.93M | -44.74M | -48.46M | -47.46M | -41.73M | -37.4M | -37.15M | -31.16M | -19.67M | -25.56M | -15.45M | -22.11M |
| Net Margin % | - | - | - | - | -867.29% | - | - | - | - | - | - | - | - | - | -28143.94% | -5813.06% | -224.39% | -684.08% | -190.12% | -996.8% |
| Net Income Growth % | -57.27% | -60.25% | -44.76% | -46.24% | -35.71% | -46.81% | -29.57% | -22.05% | -14.87% | -19.65% | -30.45% | -52.32% | -112.14% | -46.28% | -140.53% | -40.93% | -24.78% | -107.45% | -74.42% | -12533.71% |
| Net Income (Continuing) | -102.3M | -105.26M | -90.9M | -84.71M | -65.05M | -65.69M | -62.79M | -57.92M | -47.93M | -44.74M | -48.46M | -47.46M | -41.73M | -37.4M | -37.15M | -31.16M | -19.67M | -25.56M | -15.45M | -22.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.17 | -1.31 | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 | -0.75 | -0.62 | -0.64 | -0.73 | -0.72 | -0.63 | -0.57 | -0.57 | -0.55 | -0.36 | -0.62 | -0.37 | -0.53 |
| EPS Growth % | -40.96% | -55.95% | -41.98% | -42.67% | -33.87% | -31.25% | -10.96% | -4.17% | 1.59% | -12.28% | -28.07% | -30.91% | -75% | 8.06% | -54.05% | -3.77% | 16.28% | -87.88% | -48% | - |
| EPS (Basic) | -1.17 | -1.31 | -1.15 | -1.07 | -0.83 | -0.84 | -0.81 | -0.75 | -0.62 | -0.64 | -0.73 | -0.72 | -0.63 | -0.57 | -0.59 | -0.55 | -0.37 | -0.62 | -0.37 | -0.53 |
| Diluted Shares Outstanding | 87.35M | 79.25M | 79.25M | 78.95M | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 65.47M | 56.19M | 54.85M | 41.19M | 42.27M | 42.09M |
| Basic Shares Outstanding | 87.35M | 79.25M | 79.25M | 78.95M | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 62.54M | 56.19M | 53.06M | 41.19M | 41.19M | 42.09M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |